Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd.’s 2025 profit distribution plan
Securities code: 600521 Securities abbreviation: Huahai Pharmaceutical Announcement number: Lin 2026-034 Bond code: 110076 Bond abbreviation: Huahai Convertible Bonds
Zhejiang Huahai Pharmaceutical Co., Ltd.
Announcement of 2025 Profit Distribution Plan
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and bear individual and joint liability for the authenticity, accuracy and completeness of its contents.
Important content reminder:
The company’s profit distribution plan for 2025 is: a cash dividend of 0.1 yuan per share (tax included).
This profit distribution is based on the total share capital registered on the equity registration date for equity distribution, minus the number of shares in the company’s special securities account for repurchase. The specific date will be clarified in the equity distribution implementation announcement. If the company's total share capital changes before the equity registration date for equity distribution, it is planned to maintain the distribution amount per share unchanged, adjust the total distribution amount accordingly, and will separately announce the specific adjustments.
This profit distribution plan does not touch the situations that may be subject to other risk warnings as stipulated in Article 9.8.1, Item (8) of Paragraph 1 of the Shanghai Stock Exchange Stock Listing Rules (hereinafter referred to as the "Stock Listing Rules").
1. Contents of profit distribution plan
(1) Specific contents of profit distribution plan
As audited by Tianjian Accounting Firm (Special General Partnership), as of December 31, 2025, the final undistributed profit in the company's parent company's statement was RMB 9,498,699,202.62. According to the resolution of the first meeting of the company's ninth board of directors, the company plans to distribute profits in 2025 based on the total share capital registered on the equity registration date for equity distribution minus the number of shares repurchased in the company's special securities account. The profit distribution plan is as follows:
The company will distribute a cash dividend of 0.1 yuan per share (tax included) to all shareholders based on the total share capital registered on the equity registration date for equity distribution minus the number of shares in the company's special securities account for repurchase. As of April 20, 2026, the company's total share capital is 1,497,252,136 shares (the company is still in the conversion period of convertible corporate bonds). After deducting the number of 7,023,600 shares in the company's special securities account for repurchase, the calculation is based on 1,490,228,536 shares, and a total cash dividend of 149,022,853.60 yuan (including tax) is planned. The company's total cash dividends in 2025 accounted for 55.94% of the company's net profit attributable to shareholders of listed companies in 2025.
The company's shares held by the company through the repurchase special securities account will not participate in this profit distribution. as implemented
1/3
Before the equity registration date for equity distribution, if the company's total share capital changes due to the conversion of convertible bonds, the company will maintain the distribution amount per share unchanged and adjust the total distribution amount accordingly. If the total share capital changes subsequently, the company plans to announce the specific adjustments separately.
This profit distribution plan still needs to be submitted to the company's shareholders' meeting for review.
(2) Whether other risk warning situations may be involved
Item 2025 2024 Total cash dividends in 2023 (yuan) 149,022,853.60 372,556,870.25 289,815,020.20 Total repurchase and cancellation (yuan) 200,011,616.55 0 0 Net profit attributable to shareholders of listed companies (yuan) 266,399,456.11 1,118,981,177.61 830,466,003.18 Undistributed profit of the parent company at the end of the year (yuan) 9,498,699,202.62
Total cumulative cash dividends in the last three fiscal years (yuan) 811,394,744.05
Is the total cumulative cash dividend distribution in the last three fiscal years
No
Less than 50 million yuan
Cumulative total repurchase and write-off in the last three fiscal years (yuan) 200,011,616.55
Average net profit for the last three fiscal years (yuan) 738,615,545.63
Accumulated cash dividends and repurchase notes in the past three fiscal years
1,011,406,360.60
Total sales (yuan)
Cash dividend ratio (%) 136.93
Is the cash dividend ratio less than 30%? No
Whether it touches Article 9.8.1 of the Stock Listing Rules
Other risks stipulated in Item (8) of paragraph 1 may be implemented No
danger warning situation
2. Decision-making procedures implemented by the company
The company held the sixth meeting of the Audit Committee of the ninth board of directors and the first meeting of the ninth board of directors respectively, and reviewed and approved the "Company's 2025 Profit Distribution Plan". This profit distribution plan complies with the profit distribution policy and other relevant regulations stipulated in the Articles of Association. This profit distribution plan still needs to be submitted to the company's shareholders' meeting for review.
3. Related risk warnings
2/3
(1) The company’s profit distribution plan comprehensively considers the company’s development stage and future capital needs and other factors, and will not have a significant impact on the company’s operating cash flow, nor will it affect the company’s normal operations and long-term development.
(2) This profit distribution plan still needs to be submitted to the company’s shareholders’ meeting for review and approval before it can be implemented. Investors are advised to pay attention to investment risks.
Announcement is hereby made.
Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd. April 29, 2026
3/3